Haemophilia C
| Hemophilia C | |
|---|---|
| Other names | Plasma thromboplastin antecedent (PTA) deficiency, Rosenthal syndrome |
| Haemophilia C caused by deficiency in Factor XI[1] | |
| Specialty | Haematology |
| Symptoms | Oral bleeding[2] |
| Causes | Deficiency of coagulation factor XI[1] |
| Diagnostic method | Prothrombin time[1] |
| Prevention | Physical activity precautions[1] |
| Treatment | tranexamic acid[3] |
Haemophilia C (also known as plasma thromboplastin antecedent (PTA) deficiency or Rosenthal syndrome) is a mild form of haemophilia affecting both sexes, due to factor XI deficiency.[4] It predominantly occurs in Ashkenazi Jews. It is the fourth most common coagulation disorder after von Willebrand's disease and haemophilia A and B. In the United States, it is thought to affect 1 in 100,000 of the adult population, making it 10% as common as haemophilia A.[1][5]
- ^ a b c d e "Hemophilia C: Practice Essentials, Etiology, Epidemiology". eMedicine. 17 April 2024. Retrieved 21 August 2024.
- ^ Cite error: The named reference
selwas invoked but never defined (see the help page). - ^ Cite error: The named reference
refwas invoked but never defined (see the help page). - ^ "Factor XI Deficiency: Practice Essentials, Background, Pathophysiology". eMedicine. 29 June 2022. Retrieved 21 August 2024.
- ^ "Factor XI deficiency | Disease | Overview | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program". rarediseases.info.nih.gov. Archived from the original on 2019-12-16. Retrieved 2016-07-09.